Artiva Biotherapeutics (ARTV) Earnings Date, Estimates & Call Transcripts $1.80 -0.22 (-10.89%) Closing price 06/17/2025 04:00 PM EasternExtended Trading$1.86 +0.06 (+3.61%) As of 05:49 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Artiva Biotherapeutics Earnings Summary Artiva Biotherapeutics released Q1 2025 earnings on May 8, 2025, reporting an EPS of -$0.83, which missed the consensus estimate of -$0.68 by $0.15. With a trailing EPS of $0.00, Artiva Biotherapeutics' earnings are expected to grow next year, from ($4.95) to ($2.83) per share. Upcoming Q2 Earnings DateJun. 23Before Market OpensEstimatedConsensus EPS (May. 8) -$0.68 Actual EPS (May. 8) -$0.83 Missed By -$0.15 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)ARTV Upcoming EarningsArtiva Biotherapeutics' next earnings date is estimated for Monday, June 23, 2025, based on past reporting schedules. Powered by Get Artiva Biotherapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Artiva Biotherapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataARTV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Artiva Biotherapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.68-$0.62-$0.65Q2 20252-$0.71-$0.66-$0.69Q3 20252-$0.74-$0.70-$0.72Q4 20252-$0.76-$0.57-$0.67 FY 2025 8 -$2.89 -$2.55 -$2.72 Q1 20261-$0.73-$0.73-$0.73Q2 20261-$0.76-$0.76-$0.76Q3 20261-$0.78-$0.78-$0.78Q4 20261-$0.81-$0.81-$0.81 Artiva Biotherapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 6/23/2025(Estimated)--------5/8/2025--$0.68-$0.83 -$0.15-$0.83--11/12/2024--$0.68-$0.92 -$0.24-$0.92$0.30M-8/29/2024Q2 2024-$1.07-$19.10 -$18.03-$16.20-- Artiva Biotherapeutics Earnings - Frequently Asked Questions When is Artiva Biotherapeutics' earnings date? Artiva Biotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, June 23rd, 2025 based off last year's report dates. Learn more on ARTV's earnings history. Did Artiva Biotherapeutics beat their earnings estimates last quarter? In the previous quarter, Artiva Biotherapeutics (NASDAQ:ARTV) missed the analysts' consensus estimate of ($0.68) by $0.15 with a reported earnings per share (EPS) of ($0.83). Learn more on analysts' earnings estimate vs. ARTV's actual earnings. How much revenue does Artiva Biotherapeutics generate each year? Artiva Biotherapeutics (NASDAQ:ARTV) has a recorded annual revenue of $250,000.00. How much profit does Artiva Biotherapeutics generate each year? Artiva Biotherapeutics (NASDAQ:ARTV) has a recorded net income of -$65.37 million. ARTV has generated $0.00 earnings per share over the last four quarters. What is Artiva Biotherapeutics' EPS forecast for next year? Artiva Biotherapeutics' earnings are expected to grow from ($4.95) per share to ($2.83) per share in the next year. More Earnings Resources from MarketBeat Related Companies Bright Minds Biosciences Earnings Date Cybin Earnings Date ProQR Therapeutics Earnings Date Lyell Immunopharma Earnings Date Voyager Therapeutics Earnings Date Nuvectis Pharma Earnings Date Organigram Earnings Date Ventyx Biosciences Earnings Date Eledon Pharmaceuticals Earnings Date Puma Biotechnology Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:ARTV) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWhat 99% of investors are missing about Chinese AIChinese AI chatbot DeepSeek's release put the spotlight on AI and turned the tech world on its head. But 99...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored72 Hours Until Musk’s $34 Trillion AI Network BeginsIn just 72 hours, Elon Musk is expected to flip the switch on Tesla’s autonomous network in Austin, Texas. ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artiva Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artiva Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARTV Stock Free ARTV Stock Alerts